Announcements
- Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
- Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
- Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
- Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Rezolute to Participate in the Jefferies Global Healthcare Conference
- Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)
- Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
- Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
- Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)
- Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update
More ▼
Key statistics
On Wednesday, Rezolute Inc (6HV1:BER) closed at 3.34, -30.42% below its 52-week high of 4.80, set on May 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | -- |
Offer | -- |
Previous close | 3.34 |
Average volume | -- |
---|---|
Shares outstanding | 51.38m |
Free float | 45.02m |
P/E (TTM) | -- |
Market cap | 239.96m USD |
EPS (TTM) | -1.14 USD |
Data delayed at least 15 minutes, as of May 22 2024 13:10 BST.
More ▼